<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Cefditoren</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Cefditoren">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Cefditoren</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Cefditoren</b> also known as <b>cefditoren pivoxil</b> (trade names Spectracef, Meiact, and Zostum-O) is a third-generation oral cephalosporin with a broad spectrum of activity against pathogens, including both Gram-positive and -negative bacteria, and is stable to hydrolysis by many common beta-lactamases.<span class="mw-ref" id="cite_ref-Cefditoren_pivoxil:_a_review_of_its_1-0"><a href="#cite_note-Cefditoren_pivoxil:_a_review_of_its-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> USFDA (2001) approved Cefditoren pivoxil for adults and adolescents (12 years of age or older).<span class="mw-ref" id="cite_ref-autogenerated1_2-0"><a href="#cite_note-autogenerated1-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> In 2018 Zuventus healthcare ltd received approval for Cefditoren
Pivoxil dry powder for suspension (100<span>&nbsp;</span>mg / 5mL) for the treatment of mild to moderate infection also in children’s of (2 months to 12 years of age) which are caused by susceptible strains of the designated microorganisms.<span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>




<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Cefditoren</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Cefditoren.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Cefditoren.svg.png" data-file-width="945" data-file-height="518" data-file-type="drawing" height="110" width="200"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Spectracef, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/spectracef.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/spectracef.html'" tppabs="https://www.drugs.com/monograph/spectracef.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a605003.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a605003.html'" tppabs="https://medlineplus.gov/druginfo/meds/a605003.html" class="external text external">a605003</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>J01DD16<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=J01DD16  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=J01DD16'" tppabs="https://www.whocc.no/atc_ddd_index/?code=J01DD16" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(7<i>R</i>)-7-((<i>Z</i>)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((<i>Z</i>)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=104145-95-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=104145-95-1'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=104145-95-1" class="external text external">104145-95-1</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/9870843  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/9870843'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/9870843" class="external text external">9870843</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01066  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01066'" tppabs="https://www.drugbank.ca/drugs/DB01066" class="external text external">DB01066</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.8046534.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.8046534.html'" tppabs="http://www.chemspider.com/Chemical-Structure.8046534.html" class="external text external">8046534</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=81QS09V3YW  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=81QS09V3YW'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=81QS09V3YW" class="external text external">81QS09V3YW</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D07639  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D07639'" tppabs="https://www.kegg.jp/entry/D07639" class="external text external">D07639</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:59343  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:59343'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:59343" class="external text external">CHEBI:59343</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL610374  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL610374'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL610374" class="external text external">ChEMBL610374</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>19</sub><span>H</span><sub>18</sub><span>N</span><sub>6</sub><span>O</span><sub>5</sub><span>S</span><sub>3</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">506.57</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC3N2%2FC%28%3DC%28%2FC%3DC%5Cc1scnc1C%29CS%5BC%40%40H%5D2%5BC%40%40H%5D3NC%28%3DO%29C%28%3DN%5COC%29%2Fc4nc%28sc4%29N%29C%28%3DO%29O  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC3N2%2FC%28%3DC%28%2FC%3DC%5Cc1scnc1C%29CS%5BC%40%40H%5D2%5BC%40%40H%5D3NC%28%3DO%29C%28%3DN%5COC%29%2Fc4nc%28sc4%29N%29C%28%3DO%29O'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC3N2%2FC%28%3DC%28%2FC%3DC%5Cc1scnc1C%29CS%5BC%40%40H%5D2%5BC%40%40H%5D3NC%28%3DO%29C%28%3DN%5COC%29%2Fc4nc%28sc4%29N%29C%28%3DO%29O" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C3N2/C(=C(/C=C\c1scnc1C)CS[C@@H]2[C@@H]3NC(=O)C(=N\OC)/c4nc(sc4)N)C(=O)O</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C19H18N6O5S3/c1-8-11(33-7-21-8)4-3-9-5-31-17-13(16(27)25(17)14(9)18(28)29)23-15(26)12(24-30-2)10-6-32-19(20)22-10/h3-4,6-7,13,17H,5H2,1-2H3,(H2,20,22)(H,23,26)(H,28,29)/b4-3-,24-12-/t13-,17-/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:KMIPKYQIOVAHOP-YLGJWRNMSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=460023008&page2=Cefditoren  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=460023008&page2=Cefditoren'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=460023008&page2=Cefditoren" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Cefditoren pivoxil has a unique action that is Lowering IL6 &amp;K L6 to get rid from lung inflammation and epithelial damage besides bactericidal activity.<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It was patented in 1984 and approved for medical use in 1994.<span class="mw-ref" id="cite_ref-Fis2006_5-0"><a href="#cite_note-Fis2006-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Structure">Structure</h2></summary>
    
<p>Like other cephalosporins, Cefditoren has a β-lactam ring at the 7 position of cephalosporin ring, responsible for its cell wall synthesis inhibitory action. In addition to the cephem nucleus common to all cephalosporins cefditoren possesses, Aminothiazole group (Enhances activity against Gram-negative organisms), Methylthiazole group (Enhances activity against gram-positive organisms), Methoxyimino Group (β-lactamase stability), A pivoxil ester group  (Enhances oral bioavailability).<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Antimicrobial_activity">Antimicrobial activity</h2></summary>
    
<p>The spectrum of cefditoren is particularly balanced, including both Gram-positive and Gram-negative species. Strong antimicrobial activity because of the high affinity of the cefditoren for the Penicillin Binding Protein 2X (PBP 2X), responsible for cephalosporin resistance when mutated. Cefditoren pivoxil has the highest intrinsic activity on S. pneumoniae, penicillin-resistant strains included. Cefditoren holds a balanced antimicrobial spectrum that includes the three major pathogens of community- acquired LRTIs: S.  pneumoniae, H. influenzae and M. Catarrhalis.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> 
Aerobic Gram-Positive Microorganisms: Staphylococcus aureus (methicillin-susceptible strains, including ß-lactamase-producing strains), Streptococcus pneumoniae, Streptococcus pyogenes 
Aerobic Gram-Negative Microorganisms: Haemophilus influenzae (including ß-lactamase-producing strains), Haemophilus parainfluenzae (including ß-lactamase-producing strains), Moraxella catarrhalis (including ß-lactamase-producing strains.<span class="mw-ref" id="cite_ref-autogenerated1_2-1"><a href="#cite_note-autogenerated1-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacokinetics">Pharmacokinetics</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Absorption">Absorption</h3></summary>
    
<p>Oral Bioavailability-following oral administration, cefditoren pivoxil is absorbed from the gastrointestinal tract and hydrolyzed to cefditoren by esterases. Maximal plasma concentrations (Cmax) of cefditoren under fasting conditions average 1.8 ± 0.6<span>&nbsp;</span>µg/mL following 200<span>&nbsp;</span>mg dose and occur 1.5 to 3 hours following dosing. Cefditoren does not accumulate in plasma following twice daily administration to subjects with normal renal function. Under
fasting conditions, the estimated absolute bioavailability of cefditoren pivoxil is approximately 14%.<span class="mw-ref" id="cite_ref-Cefditoren_pivoxil:_a_review_of_its_1-1"><a href="#cite_note-Cefditoren_pivoxil:_a_review_of_its-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Distribution">Distribution</h3></summary>
    
<p>Binding of cefditoren to plasma proteins averages 88%, and the mean volume of distribution of cefditoren at steady state is 9.3L.
Cefditoren has been shown to penetrate into bronchial mucosa, epithelial lining fluid, skin blister fluid and tonsillar tissue and clinically relevant concentrations against common pathogens are achieved in these tissues for at least 4 hours.<span class="mw-ref" id="cite_ref-Cefditoren_pivoxil:_a_review_of_its_1-2"><a href="#cite_note-Cefditoren_pivoxil:_a_review_of_its-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Metabolism_and_Excretion">Metabolism and Excretion</h3></summary>
    
<p>Cefditoren is predominantly eliminated by the kidneys as unchanged drug and has a renal clearance of 4.1–5.6 L/h after multiple doses; its elimination half-life is 1.5 hours.<span class="mw-ref" id="cite_ref-Cefditoren_pivoxil:_a_review_of_its_1-3"><a href="#cite_note-Cefditoren_pivoxil:_a_review_of_its-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Cefditoren pivoxil is indicated to treat uncomplicated skin and skin structure infections, community-acquired pneumonia, acute bacterial exacerbation of chronic bronchitis, pharyngitis, and tonsillitis,acute maxillary sinusitis, otitis media (indications may differ between countries).<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-Cefditoren_pivoxil:_a_review_of_its_1-4"><a href="#cite_note-Cefditoren_pivoxil:_a_review_of_its-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Spectrum_of_bacterial_susceptibility">Spectrum of bacterial susceptibility</h3></summary>
    
<p>Cefditoren pivoxil has a broad spectrum of activity and has been used to treat bacterial infections of the skin and respiratory tract, including bronchitis, pneumonia, and tonsillitis. The following represents minimum inhibitory concentration data for several medically significant microorganisms.</p>
<ul><li><i>Haemophilus influenzae</i>: ≥0.063 – 0.25 μg/ml</li>
<li><i>Staphylcoccus aureus</i>: 0.25 – &gt;128 μg/ml (includes MRSA)</li>
<li><i>Streptococcus pyogenes</i>: ≤0.004 – 2 μg/ml<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></li></ul>

<p>Cefditoren is a broad-spectrum antibiotic against Gram-negative and Gram-positive bacteria, but does not have antibacterial activity against <i>Pseudomonas aeruginosa</i>.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Dosage_and_Administration">Dosage and Administration</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Adults_and_Adolescents_(≥12_Years)">Adults and Adolescents (≥12 Years)</h3></summary>
     
<ul><li>Community-Acquired Pneumonia- 400<span>&nbsp;</span>mg BID for 14 days</li>
<li>Acute Bacterial Exacerbation of Chronic Bronchitis -400<span>&nbsp;</span>mg BID for 10 days</li>
<li>Pharyngitis/Tonsillitis, otitis media, sinusitis- 200<span>&nbsp;</span>mg BID for 10 days</li>
<li>Uncomplicated Skin and Skin Structure Infections- 200<span>&nbsp;</span>mg BID for 10 days <span class="mw-ref" id="cite_ref-USFDA_11-0"><a href="#cite_note-USFDA-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></li></ul>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Children_(2_months_to_12_years_of_age)">Children (2 months to 12 years of age)</h3></summary>
    
<ul><li><b>Pneumonia, otitis media or sinusitis:</b> 3<span>&nbsp;</span>mg/kg/dose, 3 times a day, after meals. The dosage may be increased up to 6<span>&nbsp;</span>mg/kg/dose as needed, but not exceed the maximum dose for adults.</li>
<li><b>For children with diseases other than above:</b> 3<span>&nbsp;</span>mg/kg/dose, 3 times a day after meals. The dosage may be adjusted according to the disease or the patients age and symptoms, but not exceed the maximum dose for adults. Safety in low birth weight infants and newborns has not been established.<span class="mw-ref" id="cite_ref-Japanese_PI_12-0"><a href="#cite_note-Japanese_PI-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></li></ul>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pregnancy">Pregnancy</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pregnancy_Category_B">Pregnancy Category B</h3></summary>
    
<p>Cefditoren pivoxil was not teratogenic up to the highest doses tested in rats and rabbits. In rats, this dose was 1000<span>&nbsp;</span>mg/kg/day, which is approximately 24 times a human dose of 200<span>&nbsp;</span>mg BID based on mg/m2/day. In rabbits, the highest dose tested was 90<span>&nbsp;</span>mg/kg/day, which is approximately four times a human dose of 200<span>&nbsp;</span>mg BID based on mg/m2/day. This dose produced severe maternal toxicity and resulted in fetal toxicity and abortions.
In a postnatal development study in rats, cefditoren pivoxil produced no adverse effects on postnatal survival, physical and behavioral development, learning abilities, and reproductive capability at sexual maturity when tested at doses of up to 750<span>&nbsp;</span>mg/kg/day, the highest dose tested. This is approximately 18 times a human dose of 200<span>&nbsp;</span>mg BID based on mg/m2/day. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproductive studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.<span class="mw-ref" id="cite_ref-USFDA_11-1"><a href="#cite_note-USFDA-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Geriatric_Use">Geriatric Use</h2></summary>
    
<p>Of the 2675 patients in clinical studies who received cefditoren pivoxil 200<span>&nbsp;</span>mg BID, 308 (12%) were &gt;65 years of age. Of the 2159 patients in clinical studies who received cefditoren pivoxil 400<span>&nbsp;</span>mg BID, 307 (14%) were &gt;65 years of age. No clinically significant differences in effectiveness or safety were observed between older and younger patients. No dose adjustments are necessary in geriatric patients with normal (for their age) renal function. This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.<span class="mw-ref" id="cite_ref-USFDA_11-2"><a href="#cite_note-USFDA-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="International_Approvals">International Approvals</h2></summary>
    
<p>Cefditoren pivoxil is available as 200 and 400<span>&nbsp;</span>mg tablets in the United States. It was marketed under the trade name Spectracef by Vansen Pharma Inc.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span>  Cefditoren is also marketed under the name Meiact by Meiji Seika Pharma Co., Ltd.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> In INDIA it is currently marketed under the brand name "Zostum-O" by Zuventus healthcare ltd.</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Proprietary_Preparations_and_Countries">Proprietary Preparations and Countries</h3></summary>
     
<p><b>US:</b>Spectracef; <b>India:</b>Zostum-O; <b>Japan:</b>Meiact; <b>Russia:</b>Spectracef; <b>China:</b>Meiact; <b>Greece:</b>Spectracef; <b>Indonesia:</b>Meiact; <b>Italy:</b>Giasion; <b>Mexico:</b>Spectracef; <b>Portugal:</b>Meiact; <b>Thialand:</b>Meiact; <b>Turkey:</b> Cftiten, Meiact; Sefporin <b>Spain:</b> Spectracef, Meiact.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<ul><li>In patients with known allergy to the cephalosporin class of antibiotics or any of its components.</li>
<li>Patients with carnitine deficiency or inborn errors of metabolism that may result in clinically significant carnitine deficiency, because use of  cefditoren causes renal excretion of carnitine.<span class="mw-ref" id="cite_ref-USFDA_11-3"><a href="#cite_note-USFDA-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Safety_and_Tolerability">Safety and Tolerability</h2></summary>
     
<ul><li>Cefditoren pivoxil is generally well tolerated, with most adverse events being of mild-to-moderate severity and self-limiting. Gastrointestinal adverse events (e.g. diarrhoea, nausea and abdominal pain) were the most commonly reported adverse events, although they seldom led to treatment discontinuation.</li>
<li>In a postmarketing surveillance evaluating safety in 2006 children with acute otitis media treated with cefditoren (median daily dose: 10.0<span>&nbsp;</span>mg/kg with a median total treatment period of 7 days), the incidence of adverse reactions was 1.79%, without unexpected or serious adverse drug reactions reported. The most frequent adverse drug reaction was diarrhea (1.30%) that resolved or subsided during cefditoren treatment or after discontinuation or completion of therapy in all cases.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Data from the clinical studies carried out with cefditoren in the treatment of pharyngotonsillitis from 2007 to 2010 in Japan showed that the percentage of adverse events was very low and diarrhea was the most frequent event. In the largest study (734 children), the incidence of adverse reactions was 1.50% (11 events in 11 patients), with 3 events of diarrhea and three of hematuria in urinalysis without clinical symptoms. In a study carried out in children in Thailand comparing cefditoren (66 patients) with amoxicillin/clavulanic acid (72 patients) for 10 days in the treatment of acute bacterial rhinosinusitis, the most frequent adverse event was diarrhea, with significant (P = 0.02) differences in the percentages found for both compounds (4.5% with cefditoren vs. 18.1% for amoxicillin/clavulanic acid).<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Guidelines">Guidelines</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Japanese_Guidelines">Japanese Guidelines</h3></summary>
    
<ol><li>Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children recommend cefditoren pivoxil as an initial antimicrobial therapy in children (2 months and older).<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></li></ol>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="A_panel_of_70_pulmonologists,_coordinated_by_9_experts_in_respiratory_care_recommendations">A panel of 70 pulmonologists, coordinated by 9 experts in respiratory care recommendations</h3></summary>
    
<pre>* A consensus on appropriate prescribing in LRTI therapy was appraised by Delphi exercise, based on a panel of 70 pulmonologists, coordinated by a Scientific Committee of nine experts in respiratory medical care. 
* Amongst 3rd-generation oral cephalosporins, cefditoren pivoxil has the highest intrinsic activity on Streptococcus pneumoniae, penicillin-resistant strains (PEN-R)included.
* Amongst III-generation oral cephalosporins, the spectrum of cefditoren is particularly balanced, includes both Gram-positive and Gram-negative species.
* The experts expressed the opinion that, due to its high intrinsic activity, cefditoren appears as an appropriate agent for either the treatment of LRTIs and for parenteral to oral switch therapy as well.<span class="mw-ref" id="cite_ref-Delphi_18-0"><a href="#cite_note-Delphi-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></pre>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Ideal_for_Switch_over_therapy">Ideal for Switch over therapy</h2></summary>
    
<ul><li>The characteristics of oral antibiotics to be considered for the switch therapy (parenteral to oral antibiotic) are: (i) Similar antimicrobial spectrum (ii) High bioavailability (iii) Administration time 12–24 hr (iv) Good tolerability</li>
<li>The expert panel reached a high level of consensus on cefditoren pivoxil as the most appropriate option for the switch therapy from parenteral third-generation cephalosporins (like cefotaxime or ceftriaxone) to oral therapy, because of the similar spectrum and the highest intrinsic activity.<span class="mw-ref" id="cite_ref-Delphi_18-1"><a href="#cite_note-Delphi-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Cefditoren_pivoxil:_a_review_of_its-1"> <span id="mw-reference-text-cite_note-Cefditoren_pivoxil:_a_review_of_its-1" class="mw-reference-text"><cite id="CITEREFWellingtonCurran2004" class="citation journal cs1">Wellington K, Curran MP (2004). "Cefditoren pivoxil: a review of its use in the treatment of bacterial infections". <i>Drugs</i>. <b>64</b> (22): 2597–618. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200464220-00009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200464220-00009'" tppabs="https://doi.org/10.2165%2F00003495-200464220-00009" class="external text external">10.2165/00003495-200464220-00009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15516158  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15516158'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15516158" class="external text external">15516158</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:46961914  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:46961914'" tppabs="https://api.semanticscholar.org/CorpusID:46961914" class="external text external">46961914</a>.</cite></span></li><li id="cite_note-autogenerated1-2"> <span id="mw-reference-text-cite_note-autogenerated1-2" class="mw-reference-text"><cite id="CITEREFUSFDA_Prescribing_information" class="citation web cs1">USFDA Prescribing information. <a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21222lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21222lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21222lbl.pdf" class="external text external">"Spectracef"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2020</span>.</cite></span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite id="CITEREFDCGI_approval_Letter" class="citation web cs1">DCGI approval Letter. <a href="javascript:if(confirm('https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadApprovalMarketingFDC/SNDApprovalJanuryDec2018.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadApprovalMarketingFDC/SNDApprovalJanuryDec2018.pdf'" tppabs="https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadApprovalMarketingFDC/SNDApprovalJanuryDec2018.pdf" class="external text external">"Cefditoren"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2020</span>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite id="CITEREFBlasiTarsiaManteroMorlacchi2013" class="citation journal cs1">Blasi F, Tarsia P, Mantero M, Morlacchi LC, Piffer F (2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575210  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575210'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575210" class="external text external">"Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: Serum inflammatory biomarkers, clinical efficacy, and microbiological eradication"</a>. <i>Ther Clin Risk Manag</i>. <b>9</b>: 55–64. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FTCRM.S41131  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FTCRM.S41131'" tppabs="https://doi.org/10.2147%2FTCRM.S41131" class="external text external">10.2147/TCRM.S41131</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575210  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575210'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575210" class="external text external">3575210</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23430960  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23430960'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23430960" class="external text external">23430960</a>.</cite></span></li><li id="cite_note-Fis2006-5"> <span id="mw-reference-text-cite_note-Fis2006-5" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer J, Ganellin CR (2006). <a href="javascript:if(confirm('https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA496  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA496'" tppabs="https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA496" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>496. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFBalbisi2002" class="citation journal cs1">Balbisi EA (October 2002). "Cefditoren, a new aminothiazolyl cephalosporin". <i>Pharmacotherapy</i>. <b>22</b> (10): 1278–93. doi:<a href="javascript:if(confirm('https://doi.org/10.1592%2Fphco.22.15.1278.33481  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1592%2Fphco.22.15.1278.33481'" tppabs="https://doi.org/10.1592%2Fphco.22.15.1278.33481" class="external text external">10.1592/phco.22.15.1278.33481</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12389878  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12389878'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12389878" class="external text external">12389878</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFBlasiConciaDel_PratoGiusti2017" class="citation journal cs1">Blasi F, Concia E, Del Prato B, Giusti M, Mazzei T, Polistena B,  et al. (October 2017). <a href="javascript:if(confirm('https://doi.org/10.1080/1120009X.2017.1291467  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080/1120009X.2017.1291467'" tppabs="https://doi.org/10.1080/1120009X.2017.1291467" class="external text external">"The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach"</a>. <i>Journal of Chemotherapy</i>. <b>29</b> (5): 274–286. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1080%2F1120009X.2017.1291467  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F1120009X.2017.1291467'" tppabs="https://doi.org/10.1080%2F1120009X.2017.1291467" class="external text external">10.1080/1120009X.2017.1291467</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28298164  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28298164'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28298164" class="external text external">28298164</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21222lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21222lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21222lbl.pdf" class="external text external">"Cefditoren Package Insert"</a> <span class="cs1-format">(PDF)</span>. <i>fda.gov</i>. United States Food and Drug Administration<span class="reference-accessdate">. Retrieved <span class="nowrap">29 January</span> 2020</span>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.toku-e.com/Assets/MIC/Cefditoren%20sodium.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.toku-e.com/Assets/MIC/Cefditoren%20sodium.pdf'" tppabs="http://www.toku-e.com/Assets/MIC/Cefditoren%20sodium.pdf" class="external text external">"Cefditoren sodium Susceptibility and Minimum Inhibitory Concentration (MIC) Data"</a> <span class="cs1-format">(PDF)</span>. <i>TOKU-E</i>. 22 March 2020.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.wikigenes.org/e/chem/e/6436125.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wikigenes.org/e/chem/e/6436125.html'" tppabs="https://www.wikigenes.org/e/chem/e/6436125.html" class="external text external">"Disease relevance of Cefditoren"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">June 24,</span> 2014</span>.</cite></span></li><li id="cite_note-USFDA-11"> <span id="mw-reference-text-cite_note-USFDA-11" class="mw-reference-text"><cite id="CITEREFUSFDA" class="citation web cs1">USFDA. <a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021222s013s016lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021222s013s016lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021222s013s016lbl.pdf" class="external text external">"Spectracef® (cefditoren pivoxil) Tablets 200 mg and 400 mg"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">27 March</span> 2020</span>.</cite></span></li><li id="cite_note-Japanese_PI-12"> <span id="mw-reference-text-cite_note-Japanese_PI-12" class="mw-reference-text"><cite id="CITEREFMEIACT_MS_FINE_GRANULES_10%" class="citation web cs1">MEIACT MS FINE GRANULES 10%. <a href="javascript:if(confirm('https://www.kegg.jp/medicus-bin/japic_med?japic_code=00056315  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/medicus-bin/japic_med?japic_code=00056315'" tppabs="https://www.kegg.jp/medicus-bin/japic_med?japic_code=00056315" class="external text external">"Japanese PI"</a>. <i>KEGG DRUG</i><span class="reference-accessdate">. Retrieved <span class="nowrap">27 March</span> 2020</span>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process'" tppabs="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process" class="external text external">"Cefditoren"</a>. <i>fda.gov</i>. United States Food and Drug Administration<span class="reference-accessdate">. Retrieved <span class="nowrap">January 29,</span> 2020</span>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><a href="javascript:if(confirm('http://www.12buys.com/fulldescription.asp?Pdesc=Cefditoren&Ptype=Generic&Pchar=Cefditoren  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.12buys.com/fulldescription.asp?Pdesc=Cefditoren&Ptype=Generic&Pchar=Cefditoren'" tppabs="http://www.12buys.com/fulldescription.asp?Pdesc=Cefditoren&Ptype=Generic&Pchar=Cefditoren" class="external text external">Meiact Full Description</a> <a href="javascript:if(confirm('https://web.archive.org/web/20100917221510/http://12buys.com/fulldescription.asp?Pdesc=Cefditoren&Ptype=Generic&Pchar=Cefditoren  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100917221510/http://12buys.com/fulldescription.asp?Pdesc=Cefditoren&Ptype=Generic&Pchar=Cefditoren'" tppabs="https://web.archive.org/web/20100917221510/http://12buys.com/fulldescription.asp?Pdesc=Cefditoren&Ptype=Generic&Pchar=Cefditoren" class="external text external">Archived</a><span> 2010-09-17 at the </span>Wayback Machine</span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFKawamata_S,_Yamada_H,_Sato_Y,_Sasagawa_Y,_Iwama_Y,_Matumoto_M2010" class="citation journal cs1">Kawamata S, Yamada H, Sato Y, Sasagawa Y, Iwama Y, Matumoto M (2010). "Evaluation of the Safety and Efficacy of Cefditoren Pivoxil Fine Granules for Pediatric Use in Pediatric Patients With Acute Otitis Media". <i>Jpn J Antibiot</i>. <b>63</b> (3): 207–223. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20976878  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20976878'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20976878" class="external text external">20976878</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFBarberán_J,_Aguilar_L,_Giménez_MJ2012" class="citation journal cs1">Barberán J, Aguilar L, Giménez MJ (2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367410  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367410'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367410" class="external text external">"Update on the clinical utility and optimal use of cefditoren"</a>. <i>Int J Gen Med</i>. <b>5</b>: 455–464. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FIJGM.S25989  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FIJGM.S25989'" tppabs="https://doi.org/10.2147%2FIJGM.S25989" class="external text external">10.2147/IJGM.S25989</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367410  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367410'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367410" class="external text external">3367410</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22675264  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22675264'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22675264" class="external text external">22675264</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFUehara_S,_Sunakawa_K,_Eguchi_H2011" class="citation journal cs1">Uehara S, Sunakawa K, Eguchi H (2011). "Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 with focus on pneumonia". <i>Pediatr Int</i>. <b>53</b> (2): 264–276. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1442-200x.2010.03316.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1442-200x.2010.03316.x'" tppabs="https://doi.org/10.1111%2Fj.1442-200x.2010.03316.x" class="external text external">10.1111/j.1442-200x.2010.03316.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21648118  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21648118'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21648118" class="external text external">21648118</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-Delphi-18"> <span id="mw-reference-text-cite_note-Delphi-18" class="mw-reference-text"><cite id="CITEREFBlasi_F,_Concia_E,_Del_Prato_B2017" class="citation journal cs1">Blasi F, Concia E, Del Prato B (2017). <a href="javascript:if(confirm('https://doi.org/10.1080/1120009X.2017.1291467  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080/1120009X.2017.1291467'" tppabs="https://doi.org/10.1080/1120009X.2017.1291467" class="external text external">"The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach"</a>. <i>J Chemother</i>. <b>29</b> (5): 274–286. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1080%2F1120009X.2017.1291467  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F1120009X.2017.1291467'" tppabs="https://doi.org/10.1080%2F1120009X.2017.1291467" class="external text external">10.1080/1120009X.2017.1291467</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28298164  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28298164'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28298164" class="external text external">28298164</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-222_Spectracef.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-222_Spectracef.cfm'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-222_Spectracef.cfm" class="external text external">Drug Approval Package</a></li>
<li><a href="javascript:if(confirm('http://www.spectracef.com/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.spectracef.com/'" tppabs="http://www.spectracef.com/" class="external text external">Manufacturer's Product website</a></li>
<li><a href="javascript:if(confirm('https://web.archive.org/web/20071010124606/http://www.purduepharma.com/PI/Prescription/SPECTRACEF.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20071010124606/http://www.purduepharma.com/PI/Prescription/SPECTRACEF.pdf'" tppabs="https://web.archive.org/web/20071010124606/http://www.purduepharma.com/PI/Prescription/SPECTRACEF.pdf" class="external text external">Manufacturer's prescribing information for Spectracef</a></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antibacterials_active_on_the_cell_wall_and_envelope_(J01C-J01D)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antibacterials_active_on_the_cell_wall_and_envelope_(J01C-J01D)" style="font-size:114%;margin:0 4em">Antibacterials active on the cell wall and envelope (J01C-J01D)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Intracellular</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Inhibit peptidoglycan subunit synthesis and transport: <a href="N-Acetylmuramic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylmuramic_acid" title="N-Acetylmuramic acid">NAM</a> synthesis inhibition (<a href="Fosfomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfomycin" title="Fosfomycin">Fosfomycin</a>)</li>
<li>DADAL/AR inhibitors (<a href="Cycloserine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cycloserine" title="Cycloserine">Cycloserine</a>)</li>
<li>bactoprenol inhibitors (<a href="Bacitracin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bacitracin" title="Bacitracin">Bacitracin</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Glycopeptide</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Inhibit PG chain elongation: <a href="Vancomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Vancomycin" title="Vancomycin">Vancomycin</a><sup>#</sup> (Oritavancin</li>
<li>Telavancin)</li>
<li><a href="Teicoplanin.htm" tppabs="https://ptable.com/wiki/compounds/A/Teicoplanin" title="Teicoplanin">Teicoplanin</a> (Dalbavancin)</li>
<li>Ramoplanin<sup>§</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">β-lactams/<br>(inhibit PBP<br>cross-links)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Penicillins<br>(Penams)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Narrow<br>spectrum</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">β-lactamase sensitive<br>(1st generation)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Benzylpenicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylpenicillin" title="Benzylpenicillin">Benzylpenicillin (G)</a><sup>#</sup></li>
<li><a href="Benzathine_benzylpenicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzathine_benzylpenicillin" title="Benzathine benzylpenicillin">Benzathine benzylpenicillin</a><sup>#</sup></li>
<li>Procaine benzylpenicillin<sup>#</sup></li>
<li><a href="Phenoxymethylpenicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenoxymethylpenicillin" title="Phenoxymethylpenicillin">Phenoxymethylpenicillin (V)</a><sup>#</sup></li>
<li><a href="Propicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Propicillin" title="Propicillin">Propicillin</a><sup>‡</sup></li>
<li>Pheneticillin<sup>‡</sup></li>
<li>Azidocillin<sup>‡</sup></li>
<li>Clometocillin<sup>‡</sup></li>
<li>Penamecillin<sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">β-lactamase resistant<br>(2nd generation)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cloxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cloxacillin" title="Cloxacillin">Cloxacillin</a><sup>#</sup> (<a href="Dicloxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dicloxacillin" title="Dicloxacillin">Dicloxacillin</a></li>
<li><a href="Flucloxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Flucloxacillin" title="Flucloxacillin">Flucloxacillin</a>)</li>
<li><a href="Oxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxacillin" title="Oxacillin">Oxacillin</a></li>
<li><a href="Nafcillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Nafcillin" title="Nafcillin">Nafcillin</a></li>
<li>Methicillin<sup>‡</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Extended<br>spectrum</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Aminopenicillins (3rd generation)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amoxicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxicillin" title="Amoxicillin">Amoxicillin</a><sup>#</sup></li>
<li><a href="Ampicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ampicillin" title="Ampicillin">Ampicillin</a><sup>#</sup> (<a href="Pivampicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pivampicillin" title="Pivampicillin">Pivampicillin</a></li>
<li><a href="Hetacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Hetacillin" title="Hetacillin">Hetacillin</a><sup>‡</sup></li>
<li><a href="Bacampicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bacampicillin" title="Bacampicillin">Bacampicillin</a><sup>‡</sup></li>
<li>Metampicillin<sup>‡</sup></li>
<li>Talampicillin<sup>‡</sup>)</li>
<li>Epicillin<sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Carboxypenicillins (4th generation)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Ticarcillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ticarcillin" title="Ticarcillin">Ticarcillin</a></li>
<li><a href="Carbenicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbenicillin" title="Carbenicillin">Carbenicillin</a><sup>‡</sup> / Carindacillin<sup>‡</sup></li>
<li>Temocillin<sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ureidopenicillins (4th generation)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Piperacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperacillin" title="Piperacillin">Piperacillin</a></li>
<li><a href="Azlocillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Azlocillin" title="Azlocillin">Azlocillin</a><sup>‡</sup></li>
<li><a href="Mezlocillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mezlocillin" title="Mezlocillin">Mezlocillin</a><sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Mecillinam.htm" tppabs="https://ptable.com/wiki/compounds/A/Mecillinam" title="Mecillinam">Mecillinam</a><sup>‡</sup> (<a href="Pivmecillinam.htm" tppabs="https://ptable.com/wiki/compounds/A/Pivmecillinam" title="Pivmecillinam">Pivmecillinam</a><sup>‡</sup>)</li>
<li>Sulbenicillin<sup>‡</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Penems</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Faropenem<sup>‡</sup></li>
<li>Ritipenem<sup>§</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Carbapenems</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Ertapenem.htm" tppabs="https://ptable.com/wiki/compounds/A/Ertapenem" title="Ertapenem">Ertapenem</a></li>
<li>Antipseudomonal (Doripenem</li>
<li><a href="Imipenem.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipenem" title="Imipenem">Imipenem</a></li>
<li><a href="Meropenem.htm" tppabs="https://ptable.com/wiki/compounds/A/Meropenem" title="Meropenem">Meropenem</a>)</li>
<li>Biapenem<sup>‡</sup></li>
<li>Panipenem<sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cephalosporins<br>/ Cephamycins<br>(Cephems)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">1st generation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cefazolin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefazolin" title="Cefazolin">Cefazolin</a><sup>#</sup></li>
<li><a href="Cefalexin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefalexin" title="Cefalexin">Cefalexin</a> <sup>#</sup></li>
<li><a href="Cefadroxil.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefadroxil" title="Cefadroxil">Cefadroxil</a></li>
<li><a href="Cefapirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefapirin" title="Cefapirin">Cefapirin</a></li>
<li>Cefazedone<sup>‡</sup></li>
<li>Cefazaflur<sup>‡</sup></li>
<li><a href="Cefradine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefradine" title="Cefradine">Cefradine</a><sup>‡</sup></li>
<li>Cefroxadine<sup>‡</sup></li>
<li>Ceftezole<sup>‡</sup></li>
<li><a href="Cefaloglycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefaloglycin" title="Cefaloglycin">Cefaloglycin</a><sup>‡</sup></li>
<li><a href="Cefacetrile.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefacetrile" title="Cefacetrile">Cefacetrile</a><sup>‡</sup></li>
<li>Cefalonium<sup>‡</sup></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Cephaloridine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Cephaloridine'" tppabs="https://ptable.com/wiki/compounds/A/Cefaloridine" title="Cefaloridine" class="mw-redirect">Cefaloridine</a><sup>‡</sup></li>
<li><a href="Cefalotin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefalotin" title="Cefalotin">Cefalotin</a><sup>‡</sup></li>
<li>Cefatrizine<sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">2nd generation</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cefaclor.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefaclor" title="Cefaclor">Cefaclor</a></li>
<li><a href="Cefotetan.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefotetan" title="Cefotetan">Cefotetan</a></li>
<li>Cephamycin (<a href="Cefoxitin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefoxitin" title="Cefoxitin">Cefoxitin</a></li>
<li><a href="Cefprozil.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefprozil" title="Cefprozil">Cefprozil</a></li>
<li><a href="Cefuroxime.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefuroxime" title="Cefuroxime">Cefuroxime</a></li>
<li>Cefuroxime axetil</li>
<li><a href="Cefamandole.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefamandole" title="Cefamandole">Cefamandole</a><sup>‡</sup></li>
<li>Cefminox<sup>‡</sup></li>
<li><a href="Cefonicid.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefonicid" title="Cefonicid">Cefonicid</a><sup>‡</sup></li>
<li><a href="Ceforanide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ceforanide" title="Ceforanide">Ceforanide</a><sup>‡</sup></li>
<li>Cefbuperazone<sup>‡</sup></li>
<li>Cefuzonam<sup>‡</sup></li>
<li><a href="Cefmetazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefmetazole" title="Cefmetazole">Cefmetazole</a><sup>‡</sup>)</li>
<li>Carbacephem<sup>‡</sup> (<a href="Loracarbef.htm" tppabs="https://ptable.com/wiki/compounds/A/Loracarbef" title="Loracarbef">Loracarbef</a><sup>‡</sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">3rd generation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cefixime.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefixime" title="Cefixime">Cefixime</a><sup>#</sup></li>
<li><a href="Ceftriaxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ceftriaxone" title="Ceftriaxone">Ceftriaxone</a><sup>#</sup></li>
<li><a href="Cefotaxime.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefotaxime" title="Cefotaxime">Cefotaxime</a><sup>#</sup></li>
<li>Antipseudomonal (<a href="Ceftazidime.htm" tppabs="https://ptable.com/wiki/compounds/A/Ceftazidime" title="Ceftazidime">Ceftazidime</a><sup>#</sup></li>
<li><a href="Cefoperazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefoperazone" title="Cefoperazone">Cefoperazone</a><sup>‡</sup>)</li>
<li><a href="Cefdinir.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefdinir" title="Cefdinir">Cefdinir</a></li>
<li>Cefcapene</li>
<li>Cefdaloxime</li>
<li><a href="Ceftizoxime.htm" tppabs="https://ptable.com/wiki/compounds/A/Ceftizoxime" title="Ceftizoxime">Ceftizoxime</a></li>
<li><a href="Cefmenoxime.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefmenoxime" title="Cefmenoxime">Cefmenoxime</a></li>
<li><a href="Cefpiramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefpiramide" title="Cefpiramide">Cefpiramide</a></li>
<li><a href="Cefpodoxime.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefpodoxime" title="Cefpodoxime">Cefpodoxime</a></li>
<li><a href="Ceftibuten.htm" tppabs="https://ptable.com/wiki/compounds/A/Ceftibuten" title="Ceftibuten">Ceftibuten</a></li>
<li><a href="Cefditoren.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefditoren" title="Cefditoren">Cefditoren</a></li>
<li><a href="Cefotiam.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefotiam" title="Cefotiam">Cefotiam</a><sup>‡</sup></li>
<li>Cefetamet<sup>‡</sup></li>
<li>Cefodizime<sup>‡</sup></li>
<li>Cefpimizole<sup>‡</sup></li>
<li>Cefsulodin<sup>‡</sup></li>
<li>Cefteram<sup>‡</sup></li>
<li>Ceftiolene<sup>‡</sup></li>
<li>Oxacephem (Flomoxef<sup>‡</sup></li>
<li><a href="Latamoxef.htm" tppabs="https://ptable.com/wiki/compounds/A/Latamoxef" title="Latamoxef">Latamoxef</a><sup>‡</sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">4th generation</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cefepime.htm" tppabs="https://ptable.com/wiki/compounds/A/Cefepime" title="Cefepime">Cefepime</a></li>
<li>Cefozopran<sup>‡</sup></li>
<li>Cefpirome<sup>‡</sup></li>
<li>Cefquinome<sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">5th generation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Ceftaroline fosamil</li>
<li>Ceftolozane</li>
<li>Ceftobiprole</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Veterinary</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Ceftiofur</li>
<li>Cefquinome</li>
<li>Cefovecin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Monobactams</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Aztreonam.htm" tppabs="https://ptable.com/wiki/compounds/A/Aztreonam" title="Aztreonam">Aztreonam</a></li>
<li>Tigemonam<sup>‡</sup></li>
<li>Carumonam<sup>‡</sup></li>
<li>Nocardicin A<sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">β-lactamase inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Penam (Sulbactam</li>
<li><a href="Tazobactam.htm" tppabs="https://ptable.com/wiki/compounds/A/Tazobactam" title="Tazobactam">Tazobactam</a>)</li>
<li>Clavam (<a href="Clavulanic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Clavulanic_acid" title="Clavulanic acid">Clavulanic acid</a>)</li>
<li>Sulbactam</li>
<li>non-β-lactam (Relebactam</li>
<li>Avibactam</li>
<li>Vaborbactam)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combinations</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Amoxicillin/clavulanic acid<sup>#</sup></li>
<li>Imipenem/cilastatin<sup>#</sup></li>
<li>Imipenem/cilastatin/relebactam</li>
<li>Ampicillin/flucloxacillin</li>
<li>Ampicillin/sulbactam (Sultamicillin)</li>
<li>Ceftazidime/avibactam</li>
<li>Piperacillin/tazobactam</li>
<li>Ceftolozane/tazobactam</li>
<li>Cefoperazone/sulbactam</li>
<li>Meropenem/vaborbactam</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>polymyxins/detergent
<ul><li><a href="Colistin.htm" tppabs="https://ptable.com/wiki/compounds/A/Colistin" title="Colistin">Colistin</a></li>
<li><a href="Polymyxin_B.htm" tppabs="https://ptable.com/wiki/compounds/A/Polymyxin_B" title="Polymyxin B">Polymyxin B</a></li></ul></li>
<li>depolarizing
<ul><li><a href="Daptomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Daptomycin" title="Daptomycin">Daptomycin</a></li></ul></li>
<li>Hydrolyze NAM-NAG
<ul><li>lysozyme</li></ul></li>
<li>Tyrothricin
<ul><li>Gramicidin</li>
<li>Tyrocidine</li></ul></li>
<li><a href="Isoniazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoniazid" title="Isoniazid">Isoniazid</a><sup>#</sup></li>
<li>Teixobactin</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>


<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-24" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Cefditoren&oldid=969276711  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Cefditoren&oldid=969276711'" tppabs="https://en.wikipedia.org/wiki/?title=Cefditoren&oldid=969276711">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>